The global virus filtration market is expected to reach USD 6.1 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness a CAGR of 12.5% over the forecast period, increasing demand for biological products such as vaccines, therapeutic proteins, blood & blood products, cellular & gene therapy, tissue, and stem cell products is a major factor driving market growth. Biopharmaceuticals are mainly derived from human, animal, and plants and therefore require a scrutinized virus filtration procedure to avoid virus contamination in the production. Therefore, the necessity of this procedure during the production of biologics is expected to boost the market growth.
Many leading biopharmaceuticals and biotechnology manufacturers are involved in R&D to develop innovative biological products. For instance, in 2016, Pfizer Inc. invested USD 7,872.0 million in R&D, which was around 8% more than the R&D investment in 2015. This investment was mainly undertaken to boost innovation and productivity in R&D to accomplish a sustainable pipeline of vaccines and differentiated therapies with lucrative commercial opportunities. Virus filtration is an important step in biologics development, thus, the increasing R&D on biologics is expected to drive the demand for these products.
To request a sample copy or view summary of this report, click the link below:
Further Key Findings From the Report Suggest:
The consumables segment was the largest revenue generating segment of the market in 2016 owing to the increased usage of consumables including reagents, kits, and membranes in biologics downstream processing
In the technology segment, the chromatography segment is projected to grow at the highest growth rate during the forecast period. This is because of product advancements such as disposable or single-use membranes that eliminate the risk of a potential virus contaminant
The biologicals segment accounted for the largest share of the market and is projected to maintain its dominance during the forecast period due to rising prevalence of chronic diseases such as cancer, blood disorders, and diabetes
The biopharmaceutical & biotechnology companies segment is projected to grow at the highest CAGR during the forecast period because of increasing investment in R&D and production of biologics
North America dominated the overall market in 2016 primarily due to the presence of several leading biotechnology companies and increased R&D activities for the development of biologics
The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. Growing presence of CROs in Asia Pacific countries including China and India due to the presence of a large genome pool, less stringent regulations, and availability of economical labor force is contributing to the growth of this region.
Some of the major players are Merck KGaA; Sartorius; Danaher; Thermo Fisher Scientific, Inc.; Charles River Laboratories International, Inc.; GE Healthcare; Asahi Kasei Medical Co., Ltd.; WuXi PharmaTech (Cayman) Inc.; Lonza; and Clean Cells
Grand View Research has segmented the global virus filtration market on the basis of product, technology, application, end-use, and region:
Virus Filtration Product Outlook (Revenue, USD Million; 2014 - 2025)
Kits and reagents
Virus Filtration Technology Outlook (Revenue, USD Million; 2014 - 2025)
Virus Filtration Application Outlook (Revenue, USD Million; 2014 - 2025)
Vaccines and therapeutics
Blood and blood products
Cellular and gene therapy products
Tissue and tissue products
Stem cell products
Virus Filtration End-use Outlook (Revenue, USD Million; 2014 - 2025)
Biopharmaceutical & biotechnology companies
Contract research organizations
Medical devices companies
Academic institutes & research laboratories
Virus Filtration Regional Outlook (Revenue, USD Million; 2014 - 2025)
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."